Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Non-cash Items (2023 - 2025)

Zenas BioPharma (ZBIO) has 3 years of Non-cash Items data on record, last reported at $98.1 million in Q3 2025.

  • For Q3 2025, Non-cash Items rose 23.91% year-over-year to $98.1 million; the TTM value through Sep 2025 reached $98.1 million, up 23.91%, while the annual FY2024 figure was $2.1 million, 73.97% down from the prior year.
  • Non-cash Items reached $98.1 million in Q3 2025 per ZBIO's latest filing, up from $1.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $98.1 million in Q3 2025 and bottomed at $1.4 million in Q1 2025.
  • Average Non-cash Items over 3 years is $31.8 million, with a median of $5.1 million recorded in 2023.
  • Peak YoY movement for Non-cash Items: plummeted 73.97% in 2024, then rose 23.91% in 2025.
  • A 3-year view of Non-cash Items shows it stood at $8.1 million in 2023, then tumbled by 73.97% to $2.1 million in 2024, then surged by 4564.12% to $98.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $98.1 million in Q3 2025, $1.6 million in Q2 2025, and $1.4 million in Q1 2025.